EXHIBIT INDEX
QuickLinks -- Click here to rapidly navigate through this document
| Exhibit Number |
Description |
|
|---|---|---|
| 2.1(3) | Agreement and Plan of Reorganization among ProlX Pharmaceuticals Corporation, D. Xxxx Xxxxxxxxxxx, Xxxxx Xxxxx and Biomira Inc., dated October 30, 2006. | |
3.1(2) |
Amended and Restated Certificate of Incorporation of Oncothyreon Inc. |
|
3.2(2) |
Bylaws of Oncothyreon Inc. |
|
4.1(2) |
Form of Common Stock certificate. |
|
5.1(2) |
Opinion of Xxxxxx Xxxxxxx Xxxxxxxx & Xxxxxx. |
|
10.1(2) |
Form of Indemnification Agreement. |
|
10.2(1) |
Offer Letter with Xxx Xxxxxxx, dated December 16, 1985. |
|
10.3(1) |
Offer Letter with Xxxxxxx Xxxxx, dated August 10, 1989. |
|
10.4(1) |
Offer letter with Xxxxxx Xxxxxx, dated August 7, 1990. |
|
10.5(1) |
Offer Letter with Xxxxxx Xxxxxx, dated May 3, 1995. |
|
10.6†(1) |
License Agreement between Biomira Inc. and the Xxxx-Xxxxxx Cancer Institute, Inc., dated November 22, 1996. |
|
10.7(1) |
Severance Agreement between Biomira Inc. and Xxxxxx Xxxxxx, dated July 6, 1998. |
|
10.8(1) |
Severance Agreement between Biomira Inc. and Xxxxxx Xxxxxx, dated July 6, 1998. |
|
10.9†(2) |
Exclusive License Agreement between the University of Arizona and ProlX Pharmaceuticals, Inc., dated June 3, 1999. |
|
10.10†(2) |
Product Development and Clinical Supply Agreement between Biomira USA and Xxxx Imaging Corporation d.b.a. Xxxx Pharmaceutical Solutions, dated September 10, 1999. |
|
10.11†(2) |
Amended and Restated License Agreement between Imperial Cancer Research Technology Limited and Biomira Inc., dated November 14, 2000. |
|
10.12†(1) |
Exclusive License Agreement among Georgetown University, the University of Arizona and ProlX Pharmaceuticals Corporation, dated July 5, 2001. |
|
10.13(1) |
Consent and Acknowledgement among Biomira Inc., Biomira International Inc., Biomira Europe B.V., Imperial Cancer Research Technology Limited and Merck KGaA, dated February 5, 2002. |
|
10.14†(2) |
License Agreement between the Governors of the University of Alberta and Biomira Inc., dated December 1, 2001. |
|
10.15(1) |
Severance Agreement between Biomira Inc. and Xxxxxxx Xxxxx, dated May 12, 2003. |
|
10.16†(2) |
Letter Agreement between Biomira Inc. and Cancer Research Technology Limited (formerly Imperial Cancer Research Technology Limited), dated March 9, 2004. |
|
10.17(1) |
Commercial Lease Agreement between 000 X. 0xx Xx. LLC and ProlX Pharmaceuticals Corporation, dated March 26, 2004. |
|
10.18†(1) |
Exclusive License Agreement between the University of Arizona and ProlX Pharmaceuticals Corporation, dated July 29, 2004. |
|
10.19†(2) |
Adjuvant License Agreement between Biomira International Inc. and Corixa Corporation, dated October 20, 2004. |
|
10.20†(2) |
Adjuvant Supply Agreement between Biomira International Inc. and Corixa Corporation, dated October 20, 2004. |
|
10.21†(1) |
Exclusive Patent License Agreement between the University of Arizona and ProlX Pharmaceuticals Corporation, dated September 15, 2005. |
|
10.22(1) |
Letter Agreement between Xxxxxx & Xxxxxxx, LLC and Biomira Inc., dated January 10, 2006. |
|
10.23†(1) |
Amended and Restated Collaboration Agreement between Biomira B.V. and Merck KGaA, dated March 1, 2006. |
|
10.24†(1) |
Amended and Restated Supply Agreement between Biomira International Inc. and Merck KGaA, dated March 1, 2006. |
|
10.25(1) |
Severance Agreement between Biomira Inc. and Xxx Xxxxxxx, dated March 21, 2006. |
|
10.26(1) |
Consulting Agreement between Biomira Inc. and X.X. XxXxxxxxx Professional Corporation, dated July 1, 2006. |
|
10.27(1) |
Offer letter with Xxxxxx Xxxxxxx, dated August 29, 2006. |
|
10.28†(1) |
Letter Agreement between the University of Arizona and Biomira Inc., dated October 6, 2006. |
|
10.29(1) |
Offer Letter with Xxxx Xxxxxxxxxxx dated October 30, 2006. |
|
10.30(1) |
Assignment of Lease Agreement between 000 X. 0xx Xx. LLC, ProlX Pharmaceuticals Corporation and Biomira Inc. |
|
10.31(1) |
Escrow Agreement between D. Xxxx Xxxxxxxxxxx, Xxxxx Xxxxx, Xxxx X. Xxxx, ComputerShare Trust Company and Biomira Inc., dated October 30, 2006. |
|
10.32(1) |
Release and Settlement Agreement between Biomira Inc. and Xx. Xxxx XxXxxxxxx, dated December 8, 2006. |
|
10.33(1) |
Lease Agreement between W2007 Seattle Office 000 Xxxxxx Xxxxx Realty, LLC and Biomira Marketing, Inc., dated July 19, 2007. |
|
10.34(3) |
Amended and Restated Share Option Plan and form of stock option agreement thereunder. |
|
10.35(3) |
Amended and Restated Restricted Share Unit Plan. |
|
10.36(1) |
2006 Variable Pay Plan. |
|
10.37(1) |
Form of Subscription Agreement entered into between Biomira Inc. and each of the individuals and entities listed on Schedule 1 to this Exhibit 10.37, dated January 26, 2006. |
|
10.38(1) |
Form of Purchase Warrant issued by Biomira Inc. to each of the individuals and entities listed on Schedule 1 to this Exhibit 10.38, dated January 30, 2006. |
|
10.39(1) |
Letter Agreement between Xxxxxx & Xxxxxxx, LLC and Biomira Inc., dated December 1, 2006. |
|
10.40(1) |
Securities Purchase Agreement among Biomira Inc. and each of the signatories thereto, dated December 18, 2006. |
|
10.41(1) |
Form of Purchase Warrant issued by Biomira Inc. to each of the individuals and entities listed on Schedule 1 to this Exhibit 10.41, dated December 18, 2006. |
|
10.42(1) |
Purchase Warrant issued by Biomira Inc. to Xxxxxx & Xxxxxxx, LLC, dated December 18, 2006. |
|
10.43(1) |
Security Agreement between Xxxxxxx Xxxxxxx and Biomira Inc., dated November 8, 2006. |
|
10.44(1) |
General Security Agreement between Xxxxxxx Xxxxxxx and Biomira Inc., dated November 8, 2006. |
|
10.45(1) |
Security Agreement between Xxxxx Xxxxxxx and Biomira Inc., dated November 8, 2006. |
|
10.46(1) |
General Security Agreement between Xxxxx Xxxxxxx and Biomira Inc., dated November 8, 2006. |
|
10.47(1) |
Security Agreement between Xxxxxxx Xxxxx and Biomira Inc., dated November 3, 2006. |
|
10.48(1) |
General Security Agreement between Xxxxxxx Xxxxx and Biomira Inc., dated November 3, 2006. |
|
10.49(1) |
Promissory Note between Xxxxxxx Xxxxxxx and Biomira Inc., dated November 8, 2006. |
|
10.50(1) |
Promissory Note between Xxxxx Xxxxxxx and Biomira Inc., dated November 8, 2006. |
|
10.51(1) |
Promissory Note between Xxxxxxx Xxxxx and Biomira Inc., dated November 8, 2006. |
|
10.52(1) |
Letter Agreement between Xxxxxxx Xxxxx and Biomira Inc., dated May 31, 2007. |
|
23.1 |
Consent of Beach, Xxxxxxxxxx & Co., P.C., independent accounting firm, with respect to ProlX Pharmaceuticals Corporation. |
|
23.2 |
Consent of Deloitte & Touche LLP, independent registered chartered accountants, with respect to Biomira Inc. and Biomira Corporation. |
|
23.3 |
Consent of XxXxxxxxx & Xxxxx LLP, independent accounting firm, with respect to ProlX Pharmaceuticals Corporation. |
|
24.1(1) |
Power of Attorney. |
- †
- Registrant
has omitted portions of the referenced exhibit and filed such exhibit separately with the Securities and Exchange Commission pursuant to a request for
confidential treatment under Rule 406 promulgated under the United States Securities Act of 1933, as amended.
- (1)
- Previously
filed on September 12, 2007.
- (2)
- Previously
filed on September 27, 2007.
- (3)
- Previously filed on October 29, 2007.
Exhibit 23.1
CONSENT OF INDEPENDENT PUBLIC ACCOUNTING FIRM
We hereby consent to the use in this post-effective Amendment No. 1 to a Registration Statement on Form S-4 (File No. 333-145995) of our report dated September 9, 2005 relating to the financial statements of ProlX Pharmaceuticals Corporation as of and for the year ended December 31, 2004 and reference to our firm under the heading "Experts", which appears in such Registration Statement.
/s/
Beach, Xxxxxxxxxx & Co., P.C.
Beach,
Xxxxxxxxxx & Co., P.C.
Tucson, Arizona
November 6, 2007
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED CHARTERED ACCOUNTANTS
We consent to the use in this Post-Effective Amendment No. 1 to Registration Statement No. 333-145995 of our report dated September 10, 2007 (which report expresses an unqualified opinion on the financial statements and includes an explanatory paragraph relating to issuance of separate financial statements prepared under Canadian generally accepted accounting principles), relating to the financial statements of Biomira Inc. and our report dated September 24, 2007 relating to the financial statement of Biomira Corporation appearing in the Prospectus, which is part of this Registration Statement. We also consent to the reference to us under the headings "Selected Financial Data" and "Experts" in such Prospectus.
/s/ Deloitte & Touche LLP
Edmonton,
Canada
November 7, 2007
Exhibit 23.3
Consent of Independent Certified Public Accountants
We hereby consent to the use in this post-effective Amendment No. 1 to a Registration Statement on Form S-4 (File No. 333-145995) of our report dated November 21, 2006, relating to the financial statements of ProlX Pharmaceuticals Corporation as of and for the year ended December 31, 2005 and reference to our firm under the heading "Experts", which appears in such Registration Statement.
/s/ XxXxxxxxx & Xxxxx LLP
Certified
Public Accountants
Houston, Texas
November 6, 2007
EXHIBIT INDEX
CONSENT OF INDEPENDENT PUBLIC ACCOUNTING FIRM
CONSENT OF INDEPENDENT REGISTERED CHARTERED ACCOUNTANTS
Consent of Independent Certified Public Accountants
